help button home button Am J Pathol sign up for etoc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oyoshi, M. K.
Right arrow Articles by Yamamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyoshi, M. K.
Right arrow Articles by Yamamoto, K.
(American Journal of Pathology. 2003;162:1629-1638.)
© 2003 American Society for Investigative Pathology

Preferential Expansion of V{gamma}9-J{gamma}P/V{delta}2-J{delta}3 {gamma}{delta} T Cells in Nasal T-Cell Lymphoma and Chronic Active Epstein-Barr Virus Infection

Michiko K. Oyoshi*, Hiroshi Nagata*{dagger}, Nobuhiro Kimura{ddagger}, Yu Zhang*, Ayako Demachi*, Toshiro Hara§, Hirokazu Kanegane, Yoshinobu Matsuo||, Tomohiro Yamaguchi*, Tomohiro Morio**, Atsuyoshi Hirano{dagger}{dagger}, Norio Shimizu* and Kohtaro Yamamoto*

From the Department of Virology,* Division of Medical Science, Medical Research Institute, and the Department of General Medicine,** School of Medicine, Tokyo Medical and Dental University, Tokyo; the Department of Otorhinolaryngology,{dagger} Sannoh Hospital, Chiba; the First Department of Internal Medicine,{ddagger} School of Medicine, Fukuoka University, Fukuoka; the Department of Pediatrics,§ Graduate School of Medical Sciences, Kyushu University, Fukuoka; the Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama; the Fujisaki Cell Center,|| Hayashibara Biochemical Laboratories, Okayama; and the Department of Gastroenterology and Hepatology,{dagger}{dagger} School of Medicine, Yamaguchi University, Yamaguchi, Japan

We recently established an Epstein-Barr virus (EBV)-positive {gamma}{delta} T-cell line from a nasal T/natural killer (NK)-cell lymphoma (Nagata H, Konno A, Kimura N, Zhang Y, Kimura M, Demachi A, Sekine T, Yamamoto K, Shimizu N: Characterization of novel natural killer (NK)-cell and {gamma}{delta} T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 2001, 97:708–713). Subsequently, we established two novel EBV-positive {gamma}{delta} T-cell lines from the peripheral blood of patients with chronic active EBV infection. Analysis of the terminal repeat of EBV showed that the three cell lines consisted of monoclonal populations, and flow cytometry showed that they had a common phenotype of {gamma}{delta} T cells: CD3+ CD4- CD8- CD16- CD19- CD56+ CD57- HLA-DR+ T-cell receptor (TCR) {alpha}ß- TCR {gamma}{delta}+. Analysis for the expression of TCR by flow cytometry showed that all three cell lines were V{gamma}9+/V{delta}2+, but negative for V{gamma}I, V{delta}1, or V{delta}3 TCR. Southern blot analysis for TCR genes showed that the three cell lines had a common rearrangement of V{gamma}9-J{gamma}P and J{delta}3 genes. Polymerase chain reaction and sequence analysis of the junction between V{delta} and J{delta} genes revealed that the J{delta}3 genes were rearranged with the V{delta}2 genes. In contrast, none of the EBV-negative {gamma}{delta} T-cell lines, Molt-14, Peer, or Loucy, which were analyzed for controls, had V{gamma}9 or V{delta}2 TCR, or a rearrangement of J{delta}3 genes. These results indicated that V{gamma}9-J{gamma}P/V{delta}2-J{delta}3+ {gamma}{delta} T cells were preferentially affected by EBV and expanded in patients with nasal {gamma}{delta} T-cell lymphoma and chronic active EBV infection. J{delta}3+ {gamma}{delta} T cells are known to be a very minor population in {gamma}{delta} T cells of peripheral blood, whereas V{gamma}9-J{gamma}P/V{delta}2-J{delta}1+ cells are the major population. The close association of EBV with this particular {gamma}{delta} T-cell population may provide a key to the etiology of EBV-positive lymphoproliferative diseases.





This article has been cited by other articles:


Home page
NEJMHome page
J. S. Abramson, C. N. Kotton, N. Elias, D. V. Sahani, and R. P. Hasserjian
Case 8-2008 -- A 33-Year-Old Man with Fever, Abdominal Pain, and Pancytopenia after Renal Transplantation
N. Engl. J. Med., March 13, 2008; 358(11): 1176 - 1187.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. Barcy, S. C. De Rosa, J. Vieira, K. Diem, M. Ikoma, C. Casper, and L. Corey
{gamma}{delta}+ T Cells Involvement in Viral Immune Control of Chronic Human Herpesvirus 8 Infection
J. Immunol., March 1, 2008; 180(5): 3417 - 3425.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.